Agilent Technologies, Inc. (A)
NYSE • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Agilent Technologies, Inc. keeps $19 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 23
in 2 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Agilent beat expectations on both the top and bottom line in the third fiscal quarter of 2026, based on preliminary results reported August 26, 2026, with adjusted EPS of $1.62 topping the $1.49 estimate (+8.7%) and revenue of $1.878 billion topping the $1.841 billion estimate (+2%). Revenue rose ~8% to about $1.9 billion (up from about $1.7 billion a year ago), reflecting demand across its Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab businesses. Profitability translated into GAAP operating income of roughly $444 million, while net income increased ~8% to about $362 million (up from roughly $336 million a year ago). On the bottom line, adjusted EPS rose ~18% from $1.37 a year ago to $1.62. The company generated operating cash flow of about $519 million and returned cash through roughly $78 million of share repurchases alongside about $72 million in dividends. For the next period, consensus calls for EPS of $1.71 on revenue of $1.975 billion.
Next report — what to expect
Agilent Technologies, Inc. is scheduled to report earnings on November 23, 2026. Wall Street expects EPS of $1.72 on revenue of $1.99 billion; for trailing context, revenue grew +8.1% year over year last quarter. Agilent has beaten EPS in 6 of 8 most recent quarters, making guidance and segment trends key watch items.
About Agilent Technologies, Inc.
Agilent Technologies, Inc. develops instruments, software, and lab services for diagnostics and research markets, trading on the NYSE under A in the healthcare tools and laboratory-testing business. Its operations span measurement platforms, genomics and diagnostic tools, and lab support, with $6.9 billion in FY2025 revenue.
Today's Snapshot
A closed 2.8% lower at 170.38, while its sector was flat. Agilent is set to report earnings Friday. A reports earnings on 23 November.
Trading Volume
Below 10d avg (2.0M)
1.8M
vs S&P 500 Today
Outperforming Market
+0.66%
Updated: November 20, 2026 at 21:22 UTC
A Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$147.65 - $174.27Buy
- RSI (14)45.63Neutral
- Stochastic %K (14, 3, 3)38.73Neutral
- MACD Level (12, 26)0.67Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.